基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
A pioneer in the field of Cancer Immunotherapy, emergence of PD-L1/PD-1 inhibitors and next generation therapies. Focused on the future of medicine and what's possible at the intersection between engineering, science and medicine.
Experienced drug developer (from pre-clinical through Phase I-IV), entrepreneur, executive- strong communicator and strategic leader with expertise in Oncology, Immunology, Large Molecule Engineering, Virology, Filings, Biomarkers and Building/Leading Organizations.
Experienced drug developer (from pre-clinical through Phase I-IV), entrepreneur, executive- strong communicator and strategic leader with expertise in Oncology, Immunology, Large Molecule Engineering, Virology, Filings, Biomarkers and Building/Leading Organizations.
Research Interests
Papers共 305 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Dipal Mehta,Samah Alimam, Donal P. McLornan, John A. Henry,Syeda Ahmed,Arjun K. Ghosh,Sara Tyebally, John M. Walker,Riyaz Patel,Rodothea Amerikanou,Jenny ONions,Andrew J. Wilson,
Cancer Researchno. 6_Supplement (2024): 6550-6550
biorxiv(2024)
IMMUNITYno. 2 (2024): 193-195
AMERICAN ECONOMIC JOURNAL-APPLIED ECONOMICSno. 1 (2024): 314-350
Journal of Development Economicspp.103317, (2024)
Genetics in Medicine Open (2024): 101202
Journal of Behavioral and Experimental Economicspp.102218, (2024)
Daniel Chen,Tempest Plott, Michael Wiest, Will Van Trump,Ben Komalo,Dat Nguyen, Charlie Marsh,Jarred Heinrich, Colin J. Fuller, Lauren Nicolaisen, Elisa Cambronero, An Nguyen,
crossref(2024)
Patrycja S Matusik,Omar Alomar,Maryam Rafaqat Hussain, Muhammad Akrmah,Paweł T Matusik,Daniel M Chen, Muhammed Alomar,Phyllis K Stein
Reviews in cardiovascular medicineno. 1 (2024): 36-36
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn